We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$39.5B
AUM Growth
+$3.17B
Cap. Flow
+$1.77B
Cap. Flow %
4.5%
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,798
Reduced
994
Closed
66

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$26.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22M
3
AAPL icon
Apple
AAPL
+$20.6M
4
MSFT icon
Microsoft
MSFT
+$18.3M
5
T icon
AT&T
T
+$15.4M

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Technology 14.46%
3 Healthcare 12.77%
4 Industrials 10.91%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRCM
2751
DELISTED
CARE.COM, INC.
CRCM
$144K ﹤0.01%
16,786
+978
+6% +$8.6K
JMBA
2752
DELISTED
Jamba, Inc.
JMBA
$143K ﹤0.01%
13,927
+2,585
+23% +$26.8K
CMRE icon
2753
Costamare
CMRE
$1.88B
$140K ﹤0.01%
24,992
-611
-2% -$4.05K
SHLD
2754
DELISTED
Sears Holding Corporation
SHLD
$140K ﹤0.01%
15,041
-3,657
-20% -$41.7K
GNMX
2755
DELISTED
Aevi Genomic Medicine Inc
GNMX
$139K ﹤0.01%
26,911
+2,093
+8% +$11K
HIVE
2756
DELISTED
Aerohive Networks
HIVE
$139K ﹤0.01%
24,342
+1,831
+8% +$10.1K
NVIV
2757
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$139K ﹤0.01%
2
CDTX
2758
DELISTED
Cidara Therapeutics
CDTX
$138K ﹤0.01%
664
-162
-20% -$33.7K
RSYS
2759
DELISTED
Radisys Corp
RSYS
$137K ﹤0.01%
30,884
-1,635
-5% -$7.48K
AMRC icon
2760
Ameresco
AMRC
$1.12B
$136K ﹤0.01%
24,764
-600
-2% -$3.34K
FPI
2761
Farmland Partners
FPI
$408M
$136K ﹤0.01%
12,212
-186
-2% -$2.03K
NWHM
2762
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$135K ﹤0.01%
11,557
AVXL icon
2763
Anavex Life Sciences
AVXL
$255M
$133K ﹤0.01%
33,708
-1,768
-5% -$6.3K
CNTY icon
2764
Century Casinos
CNTY
$34M
$131K ﹤0.01%
15,864
+5,552
+54% +$38.3K
SYUT
2765
DELISTED
Synutra International, Inc.
SYUT
$130K ﹤0.01%
24,329
+3,439
+16% +$16.6K
GIG
2766
DELISTED
GigPeak, Inc.
GIG
$130K ﹤0.01%
51,772
+9,359
+22% +$24.1K
CTLP
2767
DELISTED
Cantaloupe
CTLP
$128K ﹤0.01%
29,791
-4,181
-12% -$19K
GDEN
2768
DELISTED
Golden Entertainment
GDEN
$128K ﹤0.01%
10,565
-2,062
-16% -$24.8K
ATHX
2769
DELISTED
Athersys, Inc. Common Stock
ATHX
$126K ﹤0.01%
3,301
+242
+8% +$10.6K
ADPT
2770
DELISTED
Adeptus Health Inc
ADPT
$125K ﹤0.01%
16,334
-2,544
-13% -$46.8K
VHC icon
2771
VirnetX Holding Corp
VHC
$54.4M
$123K ﹤0.01%
2,799
-324
-10% -$20.2K
OPCH icon
2772
Option Care Health
OPCH
$3.45B
$122K ﹤0.01%
29,384
-241
-0.8% -$1.85K
TCS
2773
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$121K ﹤0.01%
1,271
+175
+16% +$15.1K
NGVC icon
2774
Vitamin Cottage Natural Grocers
NGVC
$739M
$120K ﹤0.01%
10,097
-411
-4% -$4.88K
RLGT icon
2775
Radiant Logistics
RLGT
$386M
$120K ﹤0.01%
30,723
+4,373
+17% +$14.1K

Similar funds

RhumbLine Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, RhumbLine Advisers held 2,920 positions worth $39.5B, up 8.7% from $36.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.77B of net new capital in Q4 2016, opening 47 new positions and adding to 1,798 existing holdings. Its largest new stake was Howmet Aerospace: 952,104 shares worth $13.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $21.2M trimmed.

  • RhumbLine Advisers's largest Q4 2016 buy was Howmet Aerospace: 952,104 shares worth $13.5M.
  • RhumbLine Advisers added most to ExxonMobil in Q4 2016, an estimated $26.1M increase.
  • RhumbLine Advisers's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $21.2M.
  • RhumbLine Advisers fully exited LinkedIn Corporation in Q4 2016, selling an estimated $24.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $39.5B portfolio in Q4 2016.
  • RhumbLine Advisers opened 47 new positions and closed 66 in Q4 2016.
  • RhumbLine Advisers's portfolio value rose 8.7% quarter-over-quarter to $39.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.